Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 22, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	12,722	12,946	11,482	8,080	8,955	9,899
Market Cap Growth	5.90%	12.74%	42.11%	-9.78%	-9.54%	52.87%
Enterprise Value	11,780	12,124	10,966	7,766	8,528	9,715
Last Close Price	125.65	131.76	119.44	85.17	95.85	107.49
PE Ratio	33.71	51.84	74.32	90.18	21.99	267.54
Forward PE	16.09	21.34	22.53	24.55	22.30	29.01
PS Ratio	5.60	6.86	7.71	7.13	8.56	12.56
PB Ratio	4.68	5.80	6.72	5.88	7.95	15.54
P/TBV Ratio	4.34	5.91	6.90	5.88	7.95	15.54
P/FCF Ratio	28.91	35.80	35.56	34.66	41.15	74.82
P/OCF Ratio	26.70	33.20	33.83	31.50	39.19	67.34
PEG Ratio	0.27	0.65	0.66	1.12	0.37	0.37
EV/Sales Ratio	5.25	6.42	7.37	6.85	8.15	12.33
EV/EBITDA Ratio	18.76	29.14	41.44	35.51	25.37	41.52
EV/EBIT Ratio	19.56	30.71	44.04	37.37	26.04	42.87
EV/FCF Ratio	26.77	33.53	33.96	33.32	39.19	73.43
Debt / Equity Ratio	0.11	0.21	0.15	0.32	0.37	0.78
Debt / EBITDA Ratio	0.43	1.06	0.94	1.88	1.19	2.05
Debt / FCF Ratio	0.65	1.27	0.81	1.89	1.89	3.75
Asset Turnover	0.70	0.67	0.67	0.60	0.69	0.69
Inventory Turnover	19.20	16.48	14.85	11.71	12.59	14.73
Quick Ratio	3.98	2.25	2.49	3.65	5.14	1.41
Current Ratio	4.37	2.45	2.70	3.96	5.45	1.47
Return on Equity (ROE)	16.35%	12.68%	10.03%	7.17%	46.20%	6.62%
Return on Assets (ROA)	11.79%	8.78%	7.01%	6.82%	13.46%	12.32%
Return on Capital (ROIC)	14.26%	10.58%	8.22%	7.75%	15.33%	14.15%
Earnings Yield	3.03%	1.93%	1.35%	1.11%	4.55%	0.37%
FCF Yield	3.46%	2.79%	2.81%	2.88%	2.43%	1.34%
Buyback Yield / Dilution	-2.91%	-2.12%	-1.02%	-0.10%	-2.19%	-0.31%
Total Shareholder Return	-2.91%	-2.12%	-1.02%	-0.10%	-2.19%	-0.31%

Source: S&P Capital IQ. Standard template. Financial Sources.